270 related articles for article (PubMed ID: 21069320)
21. Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
Persia-Paulino YR; Cuevas-Perez J; Fernandez-Asensio R; Junco-Vicente A; Rozado-Castano J; Colunga S; Cigarran H; Calvo J; Laverde A; Persia O; Capin-Sampedro E
J Nucl Cardiol; 2021 Jun; 28(3):1117-1125. PubMed ID: 32333280
[TBL] [Abstract][Full Text] [Related]
22. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Chen W; Ton VK; Dilsizian V
Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
[TBL] [Abstract][Full Text] [Related]
23. An optimized imaging protocol for [
Schatka I; Bingel A; Schau F; Bluemel S; Messroghli DR; Frumkin D; Knebel F; Diekmann SM; Elsanhoury A; Tschöpe C; Hahn K; Amthauer H; Rogasch JMM; Wetz C
J Nucl Cardiol; 2021 Dec; 28(6):2483-2496. PubMed ID: 34331215
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
25. DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker.
Scully PR; Morris E; Patel KP; Treibel TA; Burniston M; Klotz E; Newton JD; Sabharwal N; Kelion A; Manisty C; Kennon S; Ozkor M; Mullen M; Hartman N; Elliott PM; Pugliese F; Hawkins PN; Moon JC; Menezes LJ
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1353-1363. PubMed ID: 32498921
[TBL] [Abstract][Full Text] [Related]
26. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis.
Azevedo Coutinho MC; Cortez-Dias N; Cantinho G; Gonçalves S; Cunha N; Rodrigues T; Santos L; Conceição I; Agostinho J; Pinto FJ
Amyloid; 2024 Mar; 31(1):32-41. PubMed ID: 37493395
[TBL] [Abstract][Full Text] [Related]
28. Standardization of
Bokhari S; Morgenstern R; Weinberg R; Kinkhabwala M; Panagiotou D; Castano A; DeLuca A; Kontak A; Jin Z; Maurer MS
J Nucl Cardiol; 2018 Feb; 25(1):181-190. PubMed ID: 27580616
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of [
Caobelli F; Gözlügöl N; Bakula A; Rominger A; Schepers R; Stortecky S; Hunziker Munsch L; Dobner S; Gräni C
J Nucl Med; 2024 Jun; 65(6):944-951. PubMed ID: 38724281
[TBL] [Abstract][Full Text] [Related]
30. Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis.
Park YJ; Lee J; Kim D; Choi JO; Kim SJ; Kim K; Choi JY
BMC Med Imaging; 2023 Jul; 23(1):92. PubMed ID: 37460984
[TBL] [Abstract][Full Text] [Related]
31. Not All Heart Uptakes on 99mTc-DPD Scintigraphy Are Amyloidosis: Chloroquine-Induced Cardiomyopathy.
Wakfie-Corieh CG; Ramos López N; Saiz-Pardo Sanz M; Pérez Castejón MJ; Vilacosta I
Clin Nucl Med; 2021 Apr; 46(4):e188-e189. PubMed ID: 33208614
[TBL] [Abstract][Full Text] [Related]
32. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
33. Myocardial uptake of
de Miguel C; Llorente L; de Haro-Del Moral FJ; García-Pavía P; González-López E; Segovia J; Krsnik I
Amyloid; 2017 Mar; 24(sup1):48-49. PubMed ID: 28434306
[No Abstract] [Full Text] [Related]
34. Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [
Minutoli F; Russo M; Di Bella G; Laudicella R; Spataro A; Vento A; Comis A; Gentile L; Mazzeo A; Vita G; Baldari S
Eur Radiol; 2022 May; 32(5):3035-3044. PubMed ID: 35031838
[TBL] [Abstract][Full Text] [Related]
35. Non-invasive detection and differentiation of cardiac amyloidosis using
Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
[TBL] [Abstract][Full Text] [Related]
36. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
37. Cardiac transthyretin amyloidosis
Löfbacka V; Axelsson J; Pilebro B; Suhr OB; Lindqvist P; Sundström T
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1822-1832. PubMed ID: 33367948
[TBL] [Abstract][Full Text] [Related]
38. Correlation Between Quantitative Uptake of
Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L
Front Cardiovasc Med; 2021; 8():663929. PubMed ID: 34722650
[No Abstract] [Full Text] [Related]
39. Quantitative
Caobelli F; Braun M; Haaf P; Wild D; Zellweger MJ
J Nucl Cardiol; 2020 Oct; 27(5):1456-1463. PubMed ID: 31538322
[TBL] [Abstract][Full Text] [Related]
40. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.
Puille M; Altland K; Linke RP; Steen-Müller MK; Kiett R; Steiner D; Bauer R
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):376-9. PubMed ID: 12002714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
